This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo
メニュー

Dr. Weimin Wang, PhD
Sanegene Bio における Founder & CEO
スピーカー

アジェンダセッション

  • LEAD (Ligand- and Enhancer-Assisted Delivery) Enables Efficient siRNA Delivery to Immune Cells by Targeting a Cell Type-Specific Receptors

    , 8:45am
    セッションを見る

このイベントで

前へ
次へ
Dr. Collin Wetzel
Associate Principal Scientist, Analytical Development
Nitto Avecia

Weimin を TIDES Asia: Oligonucleotide & Peptide Therapeutics で見る